Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
74,190,609
-
Total 13F shares
-
111,278
-
Share change
-
-386,388
-
Total reported value
-
$41,748
-
Price per share
-
$0.37
-
Number of holders
-
4
-
Value change
-
-$159,006
-
Number of buys
-
1
-
Number of sells
-
4
Institutional Holders of ENZON PHARMACEUTICALS, INC. - Common Stock, par value $0.01 per share (ENZN) as of Q3 2016
As of 30 Sep 2016,
ENZON PHARMACEUTICALS, INC. - Common Stock, par value $0.01 per share (ENZN) was held by
4 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
111,278 shares.
The largest 4 holders included
PANAGORA ASSET MANAGEMENT INC, TUDOR INVESTMENT CORP ET AL, MONARCH CAPITAL MANAGEMENT INC/, and CT Financial Advisors LLC.
This page lists
4
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.